TABLE 3.

Patient customized ASOs approved by US FDA.

S. No.	Strategy	ASO	Diseases
1	Modulation in splicing variants	Milasen	Batten Disease
2	Modulation in cryptic splicing variants	Atipeksen	Ataxia-telangiectasia mutation
3	Correction of splice	Jacifusen	ALS with FUS mutation